These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 21838332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.
    Guerrero AM, Genuino AJ, Santillan M, Praditsitthikorn N, Chantarastapornchit V, Teerawattananon Y, Alejandria M, Toral JA.
    BMC Public Health; 2015 Jul 30; 15():730. PubMed ID: 26223975
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
    Chen MK, Hung HF, Duffy S, Yen AM, Chen HH.
    J Eval Clin Pract; 2011 Dec 30; 17(6):1050-8. PubMed ID: 21679279
    [Abstract] [Full Text] [Related]

  • 5. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
    Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.
    J Natl Cancer Inst; 2002 Oct 02; 94(19):1469-83. PubMed ID: 12359856
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP.
    J Manag Care Pharm; 2010 Apr 02; 16(3):217-30. PubMed ID: 20331326
    [Abstract] [Full Text] [Related]

  • 8. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
    Gomez JA, Lepetic A, Demarteau N.
    BMC Public Health; 2014 Nov 26; 14():1222. PubMed ID: 25424716
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Benefits and costs of using HPV testing to screen for cervical cancer.
    Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K.
    JAMA; 2002 May 08; 287(18):2372-81. PubMed ID: 11988058
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.
    Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ.
    J Natl Cancer Inst; 2008 Mar 05; 100(5):308-20. PubMed ID: 18314477
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in Malaysia.
    Ezat SW, Aljunid S.
    Asian Pac J Cancer Prev; 2010 Mar 05; 11(4):943-51. PubMed ID: 21133606
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland.
    Szucs TD, Largeron N, Dedes KJ, Rafia R, Bénard S.
    Curr Med Res Opin; 2008 May 05; 24(5):1473-83. PubMed ID: 18413014
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore.
    Tay SK, Lee BW, Sohn WY, Lee IH, Mathur G, Sanicas M, Van Kriekinge G.
    Singapore Med J; 2018 Jul 05; 59(7):370-382. PubMed ID: 28983579
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.